Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8921 |
High Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD7390 |
Discontinued |
0.8394 |
Intermediate Similarity |
NPD1470 |
Approved |
0.8255 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD1201 |
Approved |
0.8207 |
Intermediate Similarity |
NPD5406 |
Approved |
0.8207 |
Intermediate Similarity |
NPD5405 |
Approved |
0.8207 |
Intermediate Similarity |
NPD5404 |
Approved |
0.8207 |
Intermediate Similarity |
NPD5408 |
Approved |
0.8112 |
Intermediate Similarity |
NPD943 |
Approved |
0.8082 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.805 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8013 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8013 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8013 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8012 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7891 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7875 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7834 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7834 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7794 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.777 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.774 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7722 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7643 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7616 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.758 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7562 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.755 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.755 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD1934 |
Approved |
0.75 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7485 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7436 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7407 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7403 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7394 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7375 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7372 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7372 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7371 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7362 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7324 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7324 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7312 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7284 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7239 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7233 |
Intermediate Similarity |
NPD920 |
Approved |
0.7229 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7191 |
Intermediate Similarity |
NPD6534 |
Approved |
0.719 |
Intermediate Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7159 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7133 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7097 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7093 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7088 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7078 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7076 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD6020 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7072 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7072 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.707 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7067 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7042 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7037 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7032 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7032 |
Intermediate Similarity |
NPD6100 |
Approved |
0.702 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7015 |
Intermediate Similarity |
NPD940 |
Approved |
0.7015 |
Intermediate Similarity |
NPD846 |
Approved |
0.7014 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7012 |
Intermediate Similarity |
NPD37 |
Approved |
0.7011 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD2798 |
Approved |
0.6977 |
Remote Similarity |
NPD7054 |
Approved |
0.6977 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6973 |
Remote Similarity |
NPD7697 |
Approved |
0.6973 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6973 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6973 |
Remote Similarity |
NPD7698 |
Approved |
0.6971 |
Remote Similarity |
NPD8313 |
Approved |
0.6971 |
Remote Similarity |
NPD8312 |
Approved |
0.6966 |
Remote Similarity |
NPD4626 |
Approved |
0.6962 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD3400 |
Discontinued |
0.6957 |
Remote Similarity |
NPD9266 |
Approved |
0.6957 |
Remote Similarity |
NPD74 |
Approved |
0.6944 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6944 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.694 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.6936 |
Remote Similarity |
NPD7472 |
Approved |
0.6935 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6935 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6919 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD3026 |
Approved |
0.6918 |
Remote Similarity |
NPD3023 |
Approved |
0.6918 |
Remote Similarity |
NPD2309 |
Approved |
0.6914 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD919 |
Approved |
0.6905 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6901 |
Remote Similarity |
NPD5951 |
Approved |
0.6897 |
Remote Similarity |
NPD3024 |
Approved |
0.6897 |
Remote Similarity |
NPD3025 |
Approved |
0.6897 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6886 |
Remote Similarity |
NPD4965 |
Approved |
0.6886 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6886 |
Remote Similarity |
NPD4966 |
Approved |
0.6884 |
Remote Similarity |
NPD9263 |
Approved |
0.6884 |
Remote Similarity |
NPD2342 |
Discontinued |
0.6884 |
Remote Similarity |
NPD9264 |
Approved |
0.6884 |
Remote Similarity |
NPD9267 |
Approved |
0.6871 |
Remote Similarity |
NPD1281 |
Approved |
0.6863 |
Remote Similarity |
NPD6663 |
Approved |
0.6857 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6855 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6846 |
Remote Similarity |
NPD1876 |
Approved |
0.6842 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6829 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6825 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6824 |
Remote Similarity |
NPD3972 |
Approved |
0.6821 |
Remote Similarity |
NPD5736 |
Approved |
0.6818 |
Remote Similarity |
NPD5028 |
Approved |
0.6818 |
Remote Similarity |
NPD4955 |
Approved |
0.6818 |
Remote Similarity |
NPD5034 |
Approved |
0.6818 |
Remote Similarity |
NPD5026 |
Approved |
0.6818 |
Remote Similarity |
NPD36 |
Approved |
0.6818 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6818 |
Remote Similarity |
NPD4954 |
Approved |
0.6811 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.681 |
Remote Similarity |
NPD5403 |
Approved |
0.6809 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD1203 |
Approved |
0.68 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6797 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6792 |
Remote Similarity |
NPD1243 |
Approved |
0.6789 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6784 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6783 |
Remote Similarity |
NPD497 |
Approved |
0.6781 |
Remote Similarity |
NPD5691 |
Approved |
0.6779 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6776 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6774 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6772 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6766 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6761 |
Remote Similarity |
NPD5030 |
Phase 2 |
0.676 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.676 |
Remote Similarity |
NPD5037 |
Approved |
0.676 |
Remote Similarity |
NPD5038 |
Approved |
0.6755
|
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |